BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 31519559)

  • 21. The prothrombotic state in cancer: pathogenic mechanisms.
    De Cicco M
    Crit Rev Oncol Hematol; 2004 Jun; 50(3):187-96. PubMed ID: 15182825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Venous and arterial thrombosis in patients who received adjuvant therapy for breast cancer.
    Saphner T; Tormey DC; Gray R
    J Clin Oncol; 1991 Feb; 9(2):286-94. PubMed ID: 1988575
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thrombophilia in cancer.
    Falanga A
    Semin Thromb Hemost; 2005 Feb; 31(1):104-10. PubMed ID: 15706482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Immunity and cancer associated thrombosis].
    Majdan A; Majdan A; Ziober-Malinowska P
    Wiad Lek; 2016; 69(4):686-692. PubMed ID: 27941211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanism and management of cancer-associated thrombosis.
    Mukai M; Oka T
    J Cardiol; 2018 Aug; 72(2):89-93. PubMed ID: 29588087
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiovascular events in cancer survivors.
    Howard E; Steingart RM; Armstrong GT; Lyon AR; Armenian SH; Teresa Voso M; Cicconi L; Coco FL; Minotti G
    Semin Oncol; 2019 Dec; 46(6):426-432. PubMed ID: 31791551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic risk factors for arterial thrombosis and inflammation.
    Ginsburg D
    Hematology Am Soc Hematol Educ Program; 2005; ():442-4. PubMed ID: 16304417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term arterial complications of chemotherapy in patients with cancer.
    Svilaas T; Lefrandt JD; Gietema JA; Kamphuisen PW
    Thromb Res; 2016 Apr; 140 Suppl 1():S109-18. PubMed ID: 27067963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Repeated arterial thrombosis as a complication of carboplatin-based chemotherapy.
    Yeung KK; Coster E; Floris Vos AW; Van der Vijgh RK; Linsen MA; Wisselink W
    Vascular; 2006; 14(1):51-4. PubMed ID: 16849025
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer-associated thrombosis and palliative care: an interview with Simon Noble.
    Noble S
    Future Oncol; 2017 Jan; 13(1):13-17. PubMed ID: 27756146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BSH Guideline: management of thrombotic and haemostatic issues in paediatric malignancy.
    Sibson KR; Biss TT; Furness CL; Grainger JD; Hough RE; Macartney C; Payne JH; Chalmers EA;
    Br J Haematol; 2018 Feb; 180(4):511-525. PubMed ID: 29384193
    [No Abstract]   [Full Text] [Related]  

  • 32. Anticancer treatment and thrombosis.
    Falanga A; Marchetti M
    Thromb Res; 2012 Mar; 129(3):353-9. PubMed ID: 22119391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Arterial bypass iterative thrombosis and cancer: three cases].
    Villemur B; Payraud E; Seetha V; De Angelis MP; Magne JL; Perennou D; Carpentier P; Pernod G
    J Mal Vasc; 2014 Feb; 39(1):14-7. PubMed ID: 24119420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cancer and thrombosis.
    Levi M
    Clin Adv Hematol Oncol; 2003 Nov; 1(11):668-71. PubMed ID: 16258468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug-related thrombosis in hematologic malignancies.
    Nadir Y; Hoffman R; Brenner B
    Rev Clin Exp Hematol; 2004 Jun; 8(1):E4. PubMed ID: 16029970
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Venous and Arterial Thrombosis: Is There a Link?
    Prandoni P
    Adv Exp Med Biol; 2017; 906():273-283. PubMed ID: 27628000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms of hypercoagulation in malignancy and during chemotherapy.
    Falanga A
    Haemostasis; 1998; 28 Suppl 3():50-60. PubMed ID: 10069762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathophysiology 1. Mechanisms of Thrombosis in Cancer Patients.
    Falanga A; Schieppati F; Russo L
    Cancer Treat Res; 2019; 179():11-36. PubMed ID: 31317478
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thrombosis in patients with cancer.
    Dhami MS; Bona RD
    Postgrad Med; 1993 Jun; 93(8):131-3,137-40. PubMed ID: 8506172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The assessment of thrombotic risk using a predictive model in metastatic cancer patients undergoing first-line therapy.
    Kim SY; Burns ZT; Henry DH
    Thromb Res; 2012 Dec; 130(6):967-70. PubMed ID: 23036533
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.